- Tickers in this article:
- BCRX
The agency authorizes emergency use of peramivir, an experimental antiviral drug, to treat swine flu.
10/25/09 - 04:27 PM EDT
WESTCHESTER COUNTY, NEW YORK - - Marek Fuchs, The Street's media critic, rants that the media jumped the CVS conference call gun.
11/06/09 - 09:37 AM EST
BioCryst Competition for IV Flu Drug: BioBuzz
U.S. government orders IV versions of two flu drugs to treat hospitalized patients.
11/06/09 - 06:29 AM EST
BioCryst Winners and Losers: BioBuzz
Sorting out the latest salvo in the H1N1 investor war
11/05/09 - 02:32 PM EST
BioCryst Ships Flu Drug to U.S. Government: BioBuzz
- Tickers in this article:
- BCRX
Initial order lower than expected but priced higher
11/05/09 - 08:03 AM EST
Cel-Sci's Lawyer Speaks: BioBuzz
Cel-Sci's complaint avoids the central issue about its mystery South African partner.
11/05/09 - 10:40 AM EST
San Diego (TheStreet) -- Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Cisco, Tessera and ImmunoGen.
11/05/09 - 08:06 AM EST
Hemispherx Cops to Ampligen FDA Delay
Disclosure raises questions about the veracity of CEO's past statements.
11/03/09 - 07:47 AM EST
Cel-Sci's South Africa Partner a Mystery
- Tickers in this article:
- CVM
Little information is available about Byron Biopharma, which was incorporated just days before its marketing deal with Cel-Sci was announced.
11/04/09 - 10:23 AM EST
San Diego (TheStreet) -- Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Celgene, Research In Motion and Berkshire Hathaway.
11/04/09 - 08:26 AM EST
San Diego (TheStreet) -- Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Bristol-Meyers Squibb, Pfizer and Agnico-Eagle Mines.
11/03/09 - 08:11 AM EST
AmerisourceBergen Profit Rises 22%
- Tickers in this article:
- ABC
AmerisourceBergen's fiscal fourth-quarter report dazzled analysts as earnings and revenue for the quarter easily beat expectations
11/03/09 - 07:53 AM EST
Connect with TheStreet